MFSD6 is an entry receptor for enterovirus D68

Lauren Varanese, Lily Xu, Christine E. Peters, Grigore Pintilie, David S. Roberts, Suyash Raj, Mengying Liu, Yaw Shin Ooi, Jonathan Diep, Wenjie Qiao, Christopher M. Richards, Jeremy Callaway, Carolyn R. Bertozzi, Sabrina Jabs, Erik Vries, Frank J. M. Kuppeveld, Claude M. Nagamine, Wah Chiu () and Jan E. Carette ()
Additional contact information
Lauren Varanese: Stanford University School of Medicine
Lily Xu: Stanford University School of Medicine
Christine E. Peters: Stanford University School of Medicine
Grigore Pintilie: Stanford University
David S. Roberts: Stanford University
Suyash Raj: Stanford University School of Medicine
Mengying Liu: Utrecht University
Yaw Shin Ooi: Duke-NUS Medical School
Jonathan Diep: Stanford University School of Medicine
Wenjie Qiao: Stanford University School of Medicine
Christopher M. Richards: Stanford University School of Medicine
Jeremy Callaway: Stanford University School of Medicine
Carolyn R. Bertozzi: Stanford University
Sabrina Jabs: Campus Kiel
Erik Vries: Utrecht University
Frank J. M. Kuppeveld: Utrecht University
Claude M. Nagamine: Stanford University School of Medicine
Wah Chiu: Stanford University School of Medicine
Jan E. Carette: Stanford University School of Medicine

Nature, 2025, vol. 641, issue 8065, 1268-1275

Abstract: Abstract With the near eradication of poliovirus due to global vaccination campaigns, attention has shifted to other enteroviruses that can cause polio-like paralysis syndrome (now termed acute flaccid myelitis)1–3. In particular, enterovirus D68 (EV-D68) is believed to be the main driver of epidemic outbreaks of acute flaccid myelitis in recent years4, yet not much is known about EV-D68 host interactions. EV-D68 is a respiratory virus5 but, in rare cases, can spread to the central nervous system to cause severe neuropathogenesis. Here we use genome-scale CRISPR screens to identify the poorly characterized multipass membrane transporter MFSD6 as a host entry factor for EV-D68. Knockout of MFSD6 expression abrogated EV-D68 infection in cell lines and primary cells corresponding to respiratory and neural cells. MFSD6 localized to the plasma membrane and was required for viral entry into host cells. MFSD6 bound directly to EV-D68 particles through its extracellular, third loop (L3). We determined the cryo-electron microscopy structure of EV-D68 in a complex with MFSD6 L3, revealing the interaction interface. A decoy receptor, engineered by fusing MFSD6 L3 to Fc, blocked EV-D68 infection of human primary lung epithelial cells and provided near-complete protection in a lethal mouse model of EV-D68 infection. Collectively, our results reveal MFSD6 as an entry receptor for EV-D68, and support the targeting of MFSD6 as a potential mechanism to combat infections by this emerging pathogen with pandemic potential.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-025-08908-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:641:y:2025:i:8065:d:10.1038_s41586-025-08908-0

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-025-08908-0

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().